Memory Disorder, Spatial
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Selective activation of α7 nicotinic acetylcholine receptor by PHA-543613 improves Aβ25-35-mediated cognitive deficits in mice.
|
25881725 |
2015 |
Memory Disorder, Spatial
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
[Gly14]-Humanin Protects Against Amyloid β Peptide-Induced Impairment of Spatial Learning and Memory in Rats.
|
27306655 |
2016 |
Memory Disorder, Spatial
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Inhibition of human high-affinity copper importer Ctr1 orthologous in the nervous system of Drosophila ameliorates Aβ42-induced Alzheimer's disease-like symptoms.
|
23827522 |
2013 |
Memory Disorder, Spatial
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Release of acetylcholinesterase (AChE) from beta-amyloid plaques assemblies improves the spatial memory impairments in APP-transgenic mice.
|
18599028 |
2008 |
Memory Disorder, Spatial
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Virgin coconut oil (VCO) by normalizing NLRP3 inflammasome showed potential neuroprotective effects in Amyloid-β induced toxicity and high-fat diet fed rat.
|
29729307 |
2018 |
Memory Disorder, Spatial
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Lactational exposure of mice to low levels of non-dioxin-like polychlorinated biphenyls increases susceptibility to neuronal stress at a mature age.
|
26480858 |
2016 |
Memory Disorder, Spatial
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-β(1-40) administration in mice: evidence for dissociation between cognitive deficits and neuronal damage.
|
20816828 |
2010 |
Memory Disorder, Spatial
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Beta-amyloid (1-42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex.
|
15364477 |
2004 |
Memory Disorder, Spatial
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Notoginsenoside R1 increases neuronal excitability and ameliorates synaptic and memory dysfunction following amyloid elevation.
|
25213453 |
2014 |
Memory Disorder, Spatial
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice.
|
19664757 |
2010 |
Memory Disorder, Spatial
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's disease.
|
28448946 |
2017 |
Memory Disorder, Spatial
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Evaluation of the protective role of melatonin on the behavioral effects of aluminum in a mouse model of Alzheimer's disease.
|
19770021 |
2009 |
Memory Disorder, Spatial
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Potassium 2-(1-hydroxypentyl)-benzoate promotes long-term potentiation in Aβ1-42-injected rats and APP/PS1 transgenic mice.
|
24858312 |
2014 |
Memory Disorder, Spatial
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Protective effects of astragalosides on dexamethasone and Aβ25-35 induced learning and memory impairments due to decrease amyloid precursor protein expression in 12-month male rats.
|
22484447 |
2012 |
Memory Disorder, Spatial
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Ethosuximide Induces Hippocampal Neurogenesis and Reverses Cognitive Deficits in an Amyloid-β Toxin-induced Alzheimer Rat Model via the Phosphatidylinositol 3-Kinase (PI3K)/Akt/Wnt/β-Catenin Pathway.
|
26420483 |
2015 |
Memory Disorder, Spatial
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Adenosine A2A receptor blockade prevents memory dysfunction caused by beta-amyloid peptides but not by scopolamine or MK-801.
|
18191838 |
2008 |